Pune, India -- (SBWIRE) -- 09/08/2017 -- Market Research Future Publish a New Report on - "Asia-Pacific Glaucoma Treatment Market Research Report- Global Forecast to 2023"

Exclusive Summery About Report:

Glaucoma is the buildup of pressure due to accumulation of eye fluids which may result in permanent blindness due to damage to the eye nerve endings. In fact glaucoma is the second most reason after cataracts causing permanent blindness. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two account for greater than 50% of glaucoma cases. Other types of glaucoma are pigmentary glaucoma, pseudoexfoliation glaucoma and normal-tension glaucoma.

The market for glaucoma treatment is growing due to factors such as rising geriatric population and rising cases of diseases such as diabetes. Other market drivers include increasing awareness, growing healthcare expenditure and screening rates.

Test the market data and market information presented through more than 60 market data tables and figures spread over 70 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on "Asia-Pacific Glaucoma Treatment Market Research Report - Forecast to 2023".

Asia-Pacific Glaucoma Treatment Market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

- Novartis AG,
- Pfizer Inc.,
- Allergan,
- Merck & Co.,
- Ocular Therapeutix Inc,
- pSivida Corp,
- Icon Bioscience Inc,
- Amorphex Therapeutics LLC.,
- Ellex, Quantel,
- Lumenis,
- Lightmed

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2962

Regional Analysis:

The healthcare sector of Asia Pacific varies immensely by countries. However the Asia Pacific region has lower public sector expenditure and most treatments involve out of pocket expenditure. Further the eye care has been a neglected segment especially in the poor countries of Asia Pacific region. Japan and South Korea are the leading markets while China will be the fastest growing due to rising healthcare expenditure and faster economic growth. Also the presence of strong generics especially in nations like India will lead to volume growth of anti-glaucoma drugs. The surgery market however will see fastest growth in Japan as compared to developing parts of Asia Pacific.

Asia-Pacific Glaucoma Treatment Market has been segmented on the basis of disease indication which comprises Closed Angle Glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. On the basis of drug class; market is segmented into prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors, and others. On the basis of surgery; market is segmented into laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy. On the basis of end users; market is segmented into hospitals and home users

If you have any special requirements, please let us know and we will offer you the report as you want.

For further information on this report, visit @ https://www.marketresearchfuture.com/reports/asia-pacific-glaucoma-treatment-market-2962

Asia-Pacific Glaucoma Treatment Market:

The Asia-Pacific Glaucoma Treatment Market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. The Asia Pacific Glaucoma Treatment market is expected to grow with CAGR of 7.5 % during the forecast period.

Table of Content

1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
Continued…..

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com